Newman Dignan & Sheerar Inc. Sells 113 Shares of Procter & Gamble Co (NYSE:PG)

Share on StockTwits

Newman Dignan & Sheerar Inc. cut its holdings in shares of Procter & Gamble Co (NYSE:PG) by 0.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 22,778 shares of the company’s stock after selling 113 shares during the quarter. Procter & Gamble comprises about 0.3% of Newman Dignan & Sheerar Inc.’s holdings, making the stock its 24th largest position. Newman Dignan & Sheerar Inc.’s holdings in Procter & Gamble were worth $2,845,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of PG. Lucia Wealth Services LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter valued at $29,000. Belmont Capital LLC acquired a new stake in shares of Procter & Gamble during the fourth quarter worth $34,000. Selective Wealth Management Inc. acquired a new stake in shares of Procter & Gamble during the third quarter worth $35,000. Princeton Global Asset Management LLC raised its stake in Procter & Gamble by 51.4% during the second quarter. Princeton Global Asset Management LLC now owns 442 shares of the company’s stock worth $48,000 after buying an additional 150 shares during the last quarter. Finally, Ironwood Financial llc raised its stake in Procter & Gamble by 27.3% during the third quarter. Ironwood Financial llc now owns 480 shares of the company’s stock worth $60,000 after buying an additional 103 shares during the last quarter. Institutional investors and hedge funds own 62.74% of the company’s stock.

A number of analysts have commented on PG shares. TheStreet raised shares of Procter & Gamble from a “c+” rating to a “b+” rating in a research report on Tuesday, October 22nd. Wells Fargo & Co lifted their price objective on Procter & Gamble from $135.00 to $136.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 23rd. Goldman Sachs Group reissued a “buy” rating and issued a $136.00 price objective on shares of Procter & Gamble in a research report on Wednesday, October 23rd. UBS Group boosted their price objective on Procter & Gamble from $122.00 to $126.00 and gave the company a “neutral” rating in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. upped their target price on Procter & Gamble from $136.00 to $139.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and seven have given a buy rating to the stock. Procter & Gamble has a consensus rating of “Hold” and a consensus price target of $119.07.

NYSE:PG opened at $125.96 on Thursday. The company has a current ratio of 0.72, a quick ratio of 0.54 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $310.95 billion, a price-to-earnings ratio of 27.87, a PEG ratio of 3.38 and a beta of 0.40. The firm has a fifty day simple moving average of $124.20 and a two-hundred day simple moving average of $120.41. Procter & Gamble Co has a 12 month low of $89.08 and a 12 month high of $126.60.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.13. Procter & Gamble had a net margin of 6.24% and a return on equity of 25.07%. The firm had revenue of $17.80 billion during the quarter, compared to the consensus estimate of $17.43 billion. During the same period in the previous year, the firm posted $1.12 earnings per share. The business’s revenue was up 6.6% compared to the same quarter last year. Equities analysts predict that Procter & Gamble Co will post 4.94 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be paid a $0.7459 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.98 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio is presently 65.93%.

In other news, CEO Steven D. Bishop sold 41,165 shares of the company’s stock in a transaction that occurred on Wednesday, October 23rd. The stock was sold at an average price of $123.36, for a total transaction of $5,078,114.40. Following the transaction, the chief executive officer now directly owns 45,176 shares of the company’s stock, valued at $5,572,911.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Valarie L. Sheppard sold 26,297 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $124.07, for a total value of $3,262,668.79. Following the transaction, the vice president now directly owns 51,694 shares in the company, valued at $6,413,674.58. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,288,513 shares of company stock valued at $159,734,252. 1.75% of the stock is currently owned by company insiders.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Recommended Story: What is meant by buying and selling pressure?

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.